Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is there an interaction between interleukin-10 and interleukin-22?

K Wolk1, E Witte, U Reineke

  • 1Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, D-10117 Berlin, Germany.

Genes and Immunity
|November 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EBV reactivation and immunoparalysis indicate a harmful immune endotype in sepsis.

Critical care (London, England)·2026
Same author

Corrigendum to "Bipedal static postural stability in children with achondroplasia compared to typically developed children in the age range of 9-12 years - A pilot study" [Gait Posture 117 (2025) 337-341].

Gait & posture·2026
Same author

Bipedal static postural stability in children with achondroplasia compared to typically developed children in the age range of 9-12 years - A pilot study.

Gait & posture·2025
Same author

Differences in Hip Muscle Strength and Static Balance in Patients with Transfemoral Amputations Classified at Different K-Levels: A Preliminary Cross-Sectional Study.

Canadian prosthetics & orthotics journal·2023
Same author

Effectiveness, safety and quality-of-life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non-interventional, prospective, German multicentre PERSIST study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same journal

Genetic regulation of platelet-derived BDNF by rs11030119: discrepancy between circulating levels and hemostatic function.

Genes and immunity·2026
Same journal

Neutrophil extracellular traps formation driven by novel ELANE mutations in cyclic neutropenia patients.

Genes and immunity·2026
Same journal

Immunogenetics in psoriasis: towards personalised diagnosis and treatment strategies.

Genes and immunity·2026
Same journal

Hyperactivation of the cGAS-STING pathway promotes liver inflammation in Down syndrome.

Genes and immunity·2026
Same journal

Immunological and prognostic impact of NRF2 in high grade serous ovarian cancer.

Genes and immunity·2026
Same journal

RASSF2 promoter hypermethylation determines malignant and microenvironmental features in lung cancer.

Genes and immunity·2026
See all related articles

Interleukin-10 (IL-10) and Interleukin-22 (IL-22) do not modulate each other's effects, despite being present during inflammation. Competition for the common IL-10R2 receptor chain was investigated but not observed between these cytokines.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Interleukin-10 (IL-10) and Interleukin-22 (IL-22) are related cytokines with distinct anti- and pro-inflammatory roles, respectively.
  • Both cytokines are simultaneously present during systemic and local inflammation.
  • Their receptors share a common chain (IL-10R2) but have unique specific chains (IL-10R1 and IL-22R1).

Purpose of the Study:

  • To investigate potential interactions and modulations between IL-10 and IL-22 signaling pathways.
  • To determine if IL-10 and IL-22 compete for the common IL-10R2 receptor chain.

Main Methods:

  • Assessing cytokine effects on monocytes and hepatocytes.
  • Verifying the dependence of cytokine action on the IL-10R2 chain.
  • Investigating interactions with native cytokines and cytokine-derived peptides.

Related Experiment Videos

Main Results:

  • No influence of IL-22 on IL-10 effects was observed, even with IL-22-binding protein.
  • No influence of IL-10 on IL-22 action was detected.
  • Lack of competition suggests native cytokines do not bind IL-10R2 without their specific R1 chain.

Conclusions:

  • IL-10 and IL-22 do not directly modulate each other's biological effects.
  • The hypothesis that binding to the specific R1 chain creates the IL-10R2 binding site is supported.
  • This finding clarifies the independent signaling of these related cytokines in inflammatory contexts.